Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2025-07-04 AGM Information
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement about the 34th Annual General Meeting (AGM) of the company Mankind Pharma Limited. It mentions the date and time of the AGM and information about e-voting. The document is a notification or announcement about the AGM, not the AGM materials or minutes themselves. It is not a full report or financial statement but an announcement related to the AGM event. The document length is 9549 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is AGM Information (AGM-R), which covers presentations and materials shared during or about the AGM, including announcements related to the AGM.
2025-07-04 English
General Updates
AGM Information Classification · 95% confidence The document is a formal letter dated July 3, 2025, addressed to stock exchanges, informing them about the date and mode of the 34th Annual General Meeting (AGM) of Mankind Pharma Limited. It mentions that the Notice of AGM along with the Annual Report will be dispatched later. The document does not contain the AGM materials or the Annual Report itself but is an announcement about the scheduling of the AGM. The document length is short (1894 characters), and it serves as an intimation or notification rather than the actual report or presentation. According to the classification rules, such a document is best classified as AGM Information (AGM-R) because it relates to the AGM and provides information about it, but it is not a report publication announcement (RPA) since it does not announce the release of a report but the meeting date and arrangements.
2025-07-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice from Mankind Pharma Limited regarding the closure of the trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs about the trading restrictions for insiders around the period of the upcoming unaudited quarterly financial results announcement for the quarter ending June 30, 2025. The document does not contain any financial data or results itself, nor does it present a report or detailed financial analysis. Instead, it is an announcement related to compliance and trading restrictions ahead of a financial disclosure. Given the content and length (1724 characters), this is a regulatory announcement related to insider trading compliance rather than a financial report or earnings release. Therefore, the appropriate classification is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2025-06-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated June 16, 2025, addressed to stock exchanges regarding the company's participation in upcoming investor conferences. It references compliance with SEBI regulations and provides a schedule of events where company officials will meet investors. The document explicitly states that no unpublished price sensitive information will be shared and is intended for information and records. There is no financial data, no detailed report, no voting results, no management changes, no legal proceedings, or any other substantive report content. The document is an announcement of participation in investor conferences, which is a regulatory disclosure but does not fit into categories like Investor Presentation (IP) because it does not contain presentation content, nor is it a report or earnings release. Given the short length (1686 characters) and nature of the content, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2025-06-16 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of equity shares under an Employee Stock Option Plan (ESOP). It references regulatory compliance under SEBI ESOP Regulations and provides detailed information about the share allotment, including number of shares, issue price, and share capital changes. The document is an announcement of a capital change due to share allotment under an employee stock option scheme. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. The primary purpose is to inform about the allotment of shares and the consequent increase in paid-up share capital. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length is 4057 characters, which is consistent with an announcement rather than a full report.
2025-06-10 English
General Updates
Environmental & Social Information Classification · 90% confidence The document is a formal communication addressed to stock exchanges regarding an ESG (Environmental, Social, and Governance) rating issued by ISS ESG for the company. It references regulatory obligations under SEBI Listing Regulations and provides the ESG score and rating. The document does not contain detailed ESG performance data or a full ESG report but rather an announcement of the ESG rating received. The length is short (1479 characters), and it serves as an intimation or notification rather than a comprehensive ESG report. Therefore, it fits best under the category of Environmental & Social Information (SR), as it relates to ESG rating disclosure under regulatory requirements.
2025-06-04 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.